- 2020
- Published
Compounds for the treatment of acute brain injury
Klein, A. B., Leurs, U., Houlton, J., Clausen, Rasmus Prætorius, Frølund, Bente, Clarkson, A. & Wellendorph, Petrine, 2020, Patent No. CN111989094, 24 Nov 2020, Priority date 1 Feb 2019, Priority No. PCT/DK2019/050041Research output: Patent
- 2017
- Published
Partial Unwinding of Transmembrane Helices Facilitates Alternating Access in the Neurotransmitter: Sodium Symporter LeuT
Merkle, P. S., Gotfryd, K., Cuendet, M. A., Leth-Espensen, K. Z., Gether, Ulrik, Loland, Claus Juul & Rand, Kasper Dyrberg, 28 Jun 2017Research output: Other contribution › Research
- 2015
- Published
New 177-lutetium labeled urokinase-type plasminogen activator receptor binding peptide conjugate, useful for treating cancer such as colorectal cancer, prostate cancer, neuroendocrine tumors, brain tumors, breast tumors and ovarian tumors
Kjær, Andreas, Persson, M. & Ploug, Michael, 8 Jul 2015, IPC No. C07K 16/ 30 A I, Patent No. CN104768573, Priority date 3 May 2013, Priority No. WO2013DK50126Research output: Patent
- 2013
- Published
Benzimidazolyl-acetamide derivatives useful as potassium channel modulators
SØRENSEN, U. S., Grunnet, Morten, Bentzen, Bo Hjorth, Christophersen, P., Diness, Jonas Goldin, SKIBSBYE, L. & Strøbæk, D., 7 Jan 2013Research output: Other contribution › Research
- 2012
- Published
Entrapment of radionuclides in nanoparticle compositions
Kjær, Andreas, 2012, Patent No. 2012079582, 22 Jun 2012Research output: Patent
- Published
New peptide-phospholipid conjugate useful for treating or preventing atherosclerosis in subject
Van Nieuwenhze, M. S., Turner, W. W., Witztum, J. L. & Hartvigsen, K., 2012, IPC No. A61K-038/10, Patent No. WO2012108990-A2, 16 Aug 2012Research output: Patent
- 2011
- Published
Reduction of parathyoid hormone levels
Hartmann, Bolette & B. Henriksen, D., 1 Apr 2011, Patent No. US2010/0081,622, 28 Sep 2009Research output: Patent
- Published
- Published
Use of glucagon-glucagon-like peptide 1 dual agonist as a positive inotropic agent for treatment of heart disease such as congestive heart failure, systolic dysfunction, myocardial infarction, and diabetic cardiomyopathy.
Petersen, J. S., Kjølbye, A. L., Skovgaard, M., Pedersen, H. D., Axelsen, L. N., Riber, D., Meier, E., Hansen, R., fosgerau, K. & Larsen, B. D., 2011, Patent No. WO2011088837-A1, 20 Nov 2011Research output: Patent
- 2010
- Published
Treatment of insulin resistance and obesity by stimulating GLP-1 release
Hansen, Harald S., Diep, T. A., Holst, Jens Juul, Rosenkilde, Mette & Andersen, N. W., 29 Dec 2010, IPC No. A61K 31/23, Patent No. PCT/DK2010/050161, 24 Jun 2010Research output: Patent
Most downloads
-
5481
downloads
Natural selection affects multiple aspects of genetic variation at putatively peutral sites across the human genome
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
4519
downloads
Family and population-based studies of variation within the ghrelin receptor locus in relation to measures of obesity
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
4515
downloads
The isoenzyme pattern of LDH does not play a physiological role; except perhaps during fast transitions in energy metabolism
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Latest publications
Evaluation of DNAmAge in paired fresh, frozen, and formalin-fixed paraffin-embedded heart tissues
Research output: Contribution to journal › Journal article › Research › peer-review
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study
Research output: Contribution to journal › Journal article › Research › peer-review
Using LanM Enzymes to Modify Glycagon-Like Peptides 1 and 2 in E.coli
Research output: Contribution to journal › Journal article › Research › peer-review